Sun Pharma Advanced Research Company Limited Share Price
Equities
SPARC
INE232I01014
Pharmaceuticals
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
257.4 INR | -5.00% | -22.61% | -10.27% |
Sales 2022 | 1.37B 16.46M | Sales 2023 | 2.39B 28.64M | Capitalization | 58.2B 698M |
---|---|---|---|---|---|
Net income 2022 | -2.03B -24.4M | Net income 2023 | -2.23B -26.7M | EV / Sales 2022 | 59.3 x |
Net Debt 2022 | 663M 7.95M | Net cash position 2023 | 3.87B 46.39M | EV / Sales 2023 | 22.8 x |
P/E ratio 2022 |
-38.4
x | P/E ratio 2023 |
-22.9
x | Employees | 407 |
Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 25.39% |
Latest transcript on Sun Pharma Advanced Research Company Limited
1 day | -5.00% | ||
1 week | -22.61% | ||
Current month | -30.12% | ||
1 month | -29.87% | ||
3 months | -30.87% | ||
6 months | +17.14% | ||
Current year | -10.27% |
Managers | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | 54 | 24/14/24 | |
Chetan Rajpara
DFI | Director of Finance/CFO | - | 01/17/01 |
Chairman | 68 | 01/06/01 |
Members of the board | Title | Age | Since |
---|---|---|---|
Chairman | 68 | 01/06/01 | |
Director/Board Member | 67 | 01/06/01 | |
Director/Board Member | 70 | 31/14/31 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.01% | 4 M€ | -4.41% | - | |
0.00% | 117 M€ | +1.11% | - | |
0.00% | 34 M€ | +2.14% | - |
Date | Price | Change | Volume |
---|---|---|---|
26/24/26 | 257.4 | -5.00% | 592,866 |
25/24/25 | 270.9 | -5.00% | 14,322,210 |
24/24/24 | 285.2 | -5.00% | 216,781 |
23/24/23 | 300.2 | -5.00% | 119,875 |
22/24/22 | 316 | -4.99% | 92,823 |
Delayed Quote NSE India S.E., April 26, 2024 at 05:13 pm IST
More quotes1st Jan change | Capi. | |
---|---|---|
-10.27% | 1B | |
+25.83% | 661B | |
+27.00% | 566B | |
-6.76% | 352B | |
+20.34% | 332B | |
+3.00% | 283B | |
+13.09% | 231B | |
+5.46% | 200B | |
-9.61% | 195B | |
-6.26% | 145B |
- Stock Market
- Equities
- SPARC Stock